Loading
IARC estimates 14,358 new cancer cases and 9,659 cancer deaths in Senegal in 2024; the commonest new cancers are cervix uteri, breast and liver and intrahepatic bile ducts. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Senegal's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 2,280 | 37.8 | Cervical cancer |
| Breast | 2,220 | 34.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 1,926 | 16.3 | Hepatocellular carcinoma |
| Prostate | 1,073 | 22.8 | Prostate cancer |
| Colorectum | 641 | 5.8 | Colorectal cancer |
| Stomach | 638 | 6.1 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 437 | 4.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Ovary | 362 | 5.9 | Ovarian cancer |
| Leukaemia | 326 | 2.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Bladder | 316 | 2.9 | Bladder & urothelial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 1,705 | 14.9 | Hepatocellular carcinoma |
| Cervix uteri | 1,362 | 23.1 | Cervical cancer |
| Breast | 1,041 | 16.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 656 | 14.0 | Prostate cancer |
| Stomach | 533 | 5.2 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 406 | 4.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 361 | 3.4 | Colorectal cancer |
| Pancreas | 300 | 2.9 | Pancreatic ductal adenocarcinoma |
| Ovary | 243 | 4.2 | Ovarian cancer |
| Leukaemia | 224 | 1.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in Senegal. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Senegal.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Senegal is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Senegal is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.